Specialty Retail
Compare Stocks
5 / 10Stock Comparison
NHTC vs AVAV vs KTOS vs QNST vs RCAT
Revenue, margins, valuation, and 5-year total return — side by side.
Aerospace & Defense
Aerospace & Defense
Advertising Agencies
Computer Hardware
NHTC vs AVAV vs KTOS vs QNST vs RCAT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Specialty Retail | Aerospace & Defense | Aerospace & Defense | Advertising Agencies | Computer Hardware |
| Market Cap | $36M | $8.40B | $10.68B | $761M | $1.02B |
| Revenue (TTM) | $38M | $1.61B | $1.42B | $1.18B | $26M |
| Net Income (TTM) | $-1M | $-224M | $29M | $-30M | $-59M |
| Gross Margin | 73.8% | 21.8% | 18.3% | 10.5% | 7.9% |
| Operating Margin | -5.1% | -8.3% | 1.8% | 1.7% | -234.6% |
| Forward P/E | — | 58.4x | 73.5x | 10.4x | 94.3x |
| Total Debt | $3M | $64M | $180M | $10M | $18M |
| Cash & Equiv. | $7M | $41M | $561M | $101M | $168M |
NHTC vs AVAV vs KTOS vs QNST vs RCAT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Natural Health Tren… (NHTC) | 100 | 42.5 | -57.5% |
| AeroVironment, Inc. (AVAV) | 100 | 237.6 | +137.6% |
| Kratos Defense & Se… (KTOS) | 100 | 312.1 | +212.1% |
| QuinStreet, Inc. (QNST) | 100 | 130.3 | +30.3% |
| Red Cat Holdings, I… (RCAT) | 100 | 901.7 | +801.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: NHTC vs AVAV vs KTOS vs QNST vs RCAT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
NHTC has the current edge in this matchup, primarily because of its strength in income & stability and defensive.
- Dividend streak 0 yrs, beta 0.58, yield 25.0%
- Beta 0.58, yield 25.0%, current ratio 2.50x
- Beta 0.58 vs RCAT's 3.31
- 25.0% yield; the other 4 pay no meaningful dividend
Among these 5 stocks, AVAV doesn't own a clear edge in any measured category.
KTOS is the #2 pick in this set and the best alternative if long-term compounding is your priority.
- 12.3% 10Y total return vs AVAV's 498.3%
- 2.1% margin vs RCAT's -227.7%
- 1.0% ROA vs RCAT's -28.8%, ROIC 1.4% vs -71.0%
QNST is the clearest fit if your priority is sleep-well-at-night.
- Lower volatility, beta 1.23, Low D/E 4.2%, current ratio 1.51x
- Lower P/E (10.4x vs 94.3x)
RCAT ranks third and is worth considering specifically for growth exposure.
- Rev growth 459.8%, EPS growth 29.4%, 3Y rev CAGR 106.6%
- 459.8% revenue growth vs NHTC's -7.4%
- +92.6% vs QNST's -26.9%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 459.8% revenue growth vs NHTC's -7.4% | |
| Value | Lower P/E (10.4x vs 94.3x) | |
| Quality / Margins | 2.1% margin vs RCAT's -227.7% | |
| Stability / Safety | Beta 0.58 vs RCAT's 3.31 | |
| Dividends | 25.0% yield; the other 4 pay no meaningful dividend | |
| Momentum (1Y) | +92.6% vs QNST's -26.9% | |
| Efficiency (ROA) | 1.0% ROA vs RCAT's -28.8%, ROIC 1.4% vs -71.0% |
NHTC vs AVAV vs KTOS vs QNST vs RCAT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
NHTC vs AVAV vs KTOS vs QNST vs RCAT — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
KTOS leads in 2 of 6 categories
QNST leads 1 • RCAT leads 1 • NHTC leads 0 • AVAV leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
KTOS leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
AVAV is the larger business by revenue, generating $1.6B annually — 62.6x RCAT's $26M. Profitability is closely matched — net margins range from 2.1% (KTOS) to -2.3% (RCAT). On growth, AVAV holds the edge at +143.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $38M | $1.6B | $1.4B | $1.2B | $26M |
| EBITDAEarnings before interest/tax | -$2M | $82M | $72M | $26M | -$58M |
| Net IncomeAfter-tax profit | -$1M | -$224M | $29M | -$30M | -$59M |
| Free Cash FlowCash after capex | -$6M | -$183M | -$133M | $99M | -$75M |
| Gross MarginGross profit ÷ Revenue | +73.8% | +21.8% | +18.3% | +10.5% | +7.9% |
| Operating MarginEBIT ÷ Revenue | -5.1% | -8.3% | +1.8% | +1.7% | -2.3% |
| Net MarginNet income ÷ Revenue | -3.0% | -13.9% | +2.1% | -2.6% | -2.3% |
| FCF MarginFCF ÷ Revenue | -16.5% | -11.3% | -9.4% | +8.4% | -2.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | -14.3% | +143.4% | +22.6% | +28.3% | — |
| EPS Growth (YoY)Latest quarter vs prior year | -2.4% | -51.5% | +133.3% | +59.4% | — |
Valuation Metrics
QNST leads this category, winning 3 of 5 comparable metrics.
Valuation Metrics
At 108.5x trailing earnings, AVAV trades at a 75% valuation discount to KTOS's 438.5x P/E. On an enterprise value basis, QNST's 21.8x EV/EBITDA is more attractive than KTOS's 118.4x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $36M | $8.4B | $10.7B | $761M | $1.0B |
| Enterprise ValueMkt cap + debt − cash | $32M | $8.4B | $10.3B | $671M | $875M |
| Trailing P/EPrice ÷ TTM EPS | -41.72x | 108.50x | 438.46x | 165.55x | -17.27x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 58.45x | 73.49x | 10.40x | 94.27x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | — |
| EV / EBITDAEnterprise value multiple | — | 102.96x | 118.42x | 21.84x | — |
| Price / SalesMarket cap ÷ Revenue | 0.90x | 10.23x | 7.93x | 0.70x | 25.15x |
| Price / BookPrice ÷ Book value/share | 1.57x | 5.34x | 4.94x | 3.19x | 5.03x |
| Price / FCFMarket cap ÷ FCF | — | — | — | 9.18x | — |
Profitability & Efficiency
KTOS leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
KTOS delivers a 1.3% return on equity — every $100 of shareholder capital generates $1 in annual profit, vs $-34 for RCAT. QNST carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to NHTC's 0.13x. On the Piotroski fundamental quality scale (0–9), QNST scores 8/9 vs NHTC's 2/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -4.9% | -6.4% | +1.3% | -11.1% | -33.6% |
| ROA (TTM)Return on assets | -2.9% | -5.0% | +1.0% | -5.9% | -28.8% |
| ROICReturn on invested capital | -6.5% | +3.6% | +1.4% | +2.8% | -71.0% |
| ROCEReturn on capital employed | -6.1% | +4.5% | +1.5% | +2.4% | -42.9% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 3 | 4 | 8 | 4 |
| Debt / EquityFinancial leverage | 0.13x | 0.07x | 0.09x | 0.04x | 0.07x |
| Net DebtTotal debt minus cash | -$4M | $23M | -$381M | -$91M | -$149M |
| Cash & Equiv.Liquid assets | $7M | $41M | $561M | $101M | $168M |
| Total DebtShort + long-term debt | $3M | $64M | $180M | $10M | $18M |
| Interest CoverageEBIT ÷ Interest expense | — | -5.99x | 6.16x | 4.64x | — |
Total Returns (Dividends Reinvested)
RCAT leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in RCAT five years ago would be worth $26,979 today (with dividends reinvested), compared to $7,160 for QNST. Over the past 12 months, RCAT leads with a +92.6% total return vs QNST's -26.9%. The 3-year compound annual growth rate (CAGR) favors RCAT at 125.5% vs NHTC's -1.9% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +7.1% | -34.4% | -28.1% | -5.1% | +13.1% |
| 1-Year ReturnPast 12 months | -20.7% | +5.1% | +58.1% | -26.9% | +92.6% |
| 3-Year ReturnCumulative with dividends | -5.7% | +63.1% | +331.5% | +81.0% | +1047.3% |
| 5-Year ReturnCumulative with dividends | -9.6% | +53.7% | +110.3% | -28.4% | +169.8% |
| 10-Year ReturnCumulative with dividends | -63.6% | +498.3% | +1231.8% | +288.4% | -97.8% |
| CAGR (3Y)Annualised 3-year return | -1.9% | +17.7% | +62.8% | +21.9% | +125.5% |
Risk & Volatility
Evenly matched — NHTC and QNST each lead in 1 of 2 comparable metrics.
Risk & Volatility
NHTC is the less volatile stock with a 0.58 beta — it tends to amplify market swings less than RCAT's 3.31 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. QNST currently trades 72.6% from its 52-week high vs AVAV's 40.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.53x | 1.55x | 1.87x | 1.23x | 3.09x |
| 52-Week HighHighest price in past year | $6.00 | $417.86 | $134.00 | $18.41 | $18.78 |
| 52-Week LowLowest price in past year | $2.40 | $155.69 | $32.85 | $10.29 | $5.23 |
| % of 52W HighCurrent price vs 52-week peak | +53.3% | +40.2% | +42.5% | +72.6% | +55.2% |
| RSI (14)Momentum oscillator 0–100 | 57.9 | 39.8 | 38.8 | 53.3 | 39.4 |
| Avg Volume (50D)Average daily shares traded | 25K | 1.7M | 4.3M | 673K | 15.8M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Analyst consensus: AVAV as "Buy", KTOS as "Buy", QNST as "Buy", RCAT as "Buy". Consensus price targets imply 104.3% upside for AVAV (target: $344) vs 12.3% for QNST (target: $15). NHTC is the only dividend payer here at 25.04% yield — a key consideration for income-focused portfolios.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | — | $343.60 | $110.58 | $15.00 | $17.00 |
| # AnalystsCovering analysts | — | 28 | 22 | 13 | 2 |
| Dividend YieldAnnual dividend ÷ price | +25.0% | — | — | — | — |
| Dividend StreakConsecutive years of raises | 0 | — | — | — | — |
| Dividend / ShareAnnual DPS | $0.80 | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
KTOS leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). QNST leads in 1 (Valuation Metrics). 1 tied.
NHTC vs AVAV vs KTOS vs QNST vs RCAT: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is NHTC or AVAV or KTOS or QNST or RCAT a better buy right now?
For growth investors, Red Cat Holdings, Inc.
(RCAT) is the stronger pick with 459. 8% revenue growth year-over-year, versus -7. 4% for Natural Health Trends Corp. (NHTC). AeroVironment, Inc. (AVAV) offers the better valuation at 108. 5x trailing P/E (58. 4x forward), making it the more compelling value choice. Analysts rate AeroVironment, Inc. (AVAV) a "Buy" — based on 28 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — NHTC or AVAV or KTOS or QNST or RCAT?
On trailing P/E, AeroVironment, Inc.
(AVAV) is the cheapest at 108. 5x versus Kratos Defense & Security Solutions, Inc. at 438. 5x. On forward P/E, QuinStreet, Inc. is actually cheaper at 10. 4x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — NHTC or AVAV or KTOS or QNST or RCAT?
Over the past 5 years, Red Cat Holdings, Inc.
(RCAT) delivered a total return of +169. 8%, compared to -28. 4% for QuinStreet, Inc. (QNST). Over 10 years, the gap is even starker: KTOS returned +1253% versus RCAT's -97. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — NHTC or AVAV or KTOS or QNST or RCAT?
By beta (market sensitivity over 5 years), Natural Health Trends Corp.
(NHTC) is the lower-risk stock at 0. 53β versus Red Cat Holdings, Inc. 's 3. 09β — meaning RCAT is approximately 482% more volatile than NHTC relative to the S&P 500. On balance sheet safety, QuinStreet, Inc. (QNST) carries a lower debt/equity ratio of 4% versus 13% for Natural Health Trends Corp. — giving it more financial flexibility in a downturn.
05Which is growing faster — NHTC or AVAV or KTOS or QNST or RCAT?
By revenue growth (latest reported year), Red Cat Holdings, Inc.
(RCAT) is pulling ahead at 459. 8% versus -7. 4% for Natural Health Trends Corp. (NHTC). On earnings-per-share growth, the picture is similar: QuinStreet, Inc. grew EPS 114. 2% year-over-year, compared to -254. 0% for Natural Health Trends Corp.. Over a 3-year CAGR, RCAT leads at 106. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — NHTC or AVAV or KTOS or QNST or RCAT?
AeroVironment, Inc.
(AVAV) is the more profitable company, earning 5. 3% net margin versus -177. 0% for Red Cat Holdings, Inc. — meaning it keeps 5. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AVAV leads at 5. 0% versus -163. 5% for RCAT. At the gross margin level — before operating expenses — NHTC leads at 73. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is NHTC or AVAV or KTOS or QNST or RCAT more undervalued right now?
On forward earnings alone, QuinStreet, Inc.
(QNST) trades at 10. 4x forward P/E versus 94. 3x for Red Cat Holdings, Inc. — 83. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for AVAV: 104. 3% to $343. 60.
08Which pays a better dividend — NHTC or AVAV or KTOS or QNST or RCAT?
In this comparison, NHTC (25.
0% yield) pays a dividend. AVAV, KTOS, QNST, RCAT do not pay a meaningful dividend and should not be held primarily for income.
09Is NHTC or AVAV or KTOS or QNST or RCAT better for a retirement portfolio?
For long-horizon retirement investors, Natural Health Trends Corp.
(NHTC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 53), 25. 0% yield). Red Cat Holdings, Inc. (RCAT) carries a higher beta of 3. 09 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (NHTC: -63. 9%, RCAT: -97. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between NHTC and AVAV and KTOS and QNST and RCAT?
These companies operate in different sectors (NHTC (Consumer Cyclical) and AVAV (Industrials) and KTOS (Industrials) and QNST (Communication Services) and RCAT (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: NHTC is a small-cap income-oriented stock; AVAV is a small-cap quality compounder stock; KTOS is a mid-cap high-growth stock; QNST is a small-cap high-growth stock; RCAT is a small-cap high-growth stock. NHTC pays a dividend while AVAV, KTOS, QNST, RCAT do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.